Your browser doesn't support javascript.
loading
Generation of in situ CRISPR-mediated primary and metastatic cancer from monkey liver.
Zhong, Liping; Huang, Yong; He, Jian; Yang, Nuo; Xu, Banghao; Ma, Yun; Liu, Junjie; Tang, Chao; Luo, Chengpiao; Wu, Pan; Lai, Zongqiang; Huo, Yu; Lu, Tao; Huang, Dongni; Gong, Wenlin; Gan, Lu; Luo, Yiqun; Zhang, Zhikun; Liu, Xiyu; Zhao, Yongxiang.
Affiliation
  • Zhong L; National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Huang Y; National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • He J; National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Yang N; National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Xu B; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Ma Y; Department of Pathology, Tumor Hospital, Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Liu J; Department of Ultrasound Imaging, Tumor Hospital, Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Tang C; National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Luo C; Department of Pathology, Tumor Hospital, Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Wu P; National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Lai Z; National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Huo Y; National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Lu T; National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Huang D; National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Gong W; National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Gan L; National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Luo Y; National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Zhang Z; National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Liu X; National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Zhao Y; National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Guangxi Medical University, Nanning, Guangxi, 530021, China. yongxiang_zhao@126.com.
Signal Transduct Target Ther ; 6(1): 411, 2021 12 03.
Article in En | MEDLINE | ID: mdl-34857736
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / PTEN Phosphohydrolase / INDEL Mutation / CRISPR-Cas Systems / Liver Neoplasms Limits: Animals Language: En Journal: Signal Transduct Target Ther Year: 2021 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / PTEN Phosphohydrolase / INDEL Mutation / CRISPR-Cas Systems / Liver Neoplasms Limits: Animals Language: En Journal: Signal Transduct Target Ther Year: 2021 Document type: Article Affiliation country: China